Skip to main content
The American Journal of Clinical Nutrition logoLink to The American Journal of Clinical Nutrition
. 2017 Apr;105(4):1021. doi: 10.3945/ajcn.117.154013

Erratum for Chang et al. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 2014;99:320–7.

PMCID: PMC5366058  PMID: 28373320

Erratum for Chang et al. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 2014;99:320–7.

In the published article, Tables 3 and 4 contain errors. The coefficients and P values above the knots actually represent the marginal change (i.e., the change in the slope from the preceding interval). For instance, it was incorrectly stated that phosphorus density ≥0.35 mg/kcal was associated with cardiovascular mortality (Table 4). Rather, the coefficients and P values show that the relation between phosphorus density and cardiovascular mortality significantly changes with phosphorus density ≥0.35 mg/kcal compared with phosphorus density <0.35 mg/kcal. However, there was no significant association between phosphorus density and cardiovascular mortality above 0.35 mg/kcal (corrected Table 4).

CORRECTED TABLE 3.

Adjusted HRs (95% CIs) of all-cause and CVD mortality according to absolute phosphorus intake1

Model 1
Model 2
Adjusted HR (95% CI) P Adjusted HR (95% CI) P
All-cause mortality2
 Below ln (1400 mg/d) 0.78 (0.51, 1.20) 0.2 0.96 (0.64, 1.43) 0.8
 At or above ln (1400 mg/d) 1.75 (1.05, 2.94) 0.03 1.89 (1.03, 3.46) 0.04
CVD mortality2
 Below ln (1400 mg/d) 0.89 (0.42, 1.88) 0.8 0.99 (0.46, 2.14) 1.0
 At or above ln (1400 mg/d) 0.94 (0.26, 3.37) 0.9 1.02 (0.29, 3.58) 1.0
1

Cox proportional hazards regression was used to estimate HRs of mortality by absolute phosphorus intake. Absolute phosphorus intake was log-transformed to achieve a more normal distribution and modeled continuously by using linear splines with a knot at ln (1400 mg/d) on the basis of evidence of a nonlinear relation. Model 1 was adjusted for age, sex, race, ethnicity, poverty:income ratio, and total energy intake. Model 2 was adjusted as for model 1 covariates and for BMI, systolic blood pressure, current and former smoking, physical activity, non-HDL cholesterol, log albumin:creatinine ratio, estimated glomerular filtration rate, and low vitamin D concentration. CVD, cardiovascular disease.

2

Continuous [per 1-unit increase in ln (phosphorus intake, mg/d)].

CORRECTED TABLE 4.

Adjusted HRs (95% CIs) of all-cause and CVD mortality according to phosphorus density1

Model 1
Model 2
Adjusted HR (95% CI) P Adjusted HR (95% CI) P
All-cause mortality2
 <0.35 mg/kcal 0.36 (0.20, 0.66) 0.001 0.46 (0.24, 0.89) 0.02
 ≥0.35 mg/kcal 1.03 (0.99,1.08) 0.2 1.05 (1.01, 1.10) 0.01
CVD mortality2
 <0.35 mg/kcal 0.22 (0.10, 0.48) <0.001 0.30 (0.13, 0.73) 0.01
 ≥0.35 mg/kcal 1.02 (0.94, 1.11) 0.6 1.02 (0.93, 1.12) 0.6
1

Cox proportional hazards regression was used to estimate HRs of mortality by phosphorus density. Phosphorus density was modeled as a continuous variable by using linear splines (knot at 0.35 mg/kcal, which corresponds to 700 mg for a 2000-kcal diet) on the basis of a visual inspection of locally weighted smoothing plots. Model 1 was adjusted for age, sex, race, ethnicity, poverty:income ratio, and total energy intake. Model 2 was adjusted as for model 1 covariates and for BMI, systolic blood pressure, current and former smoking, physical activity, non-HDL cholesterol, log albumin:creatinine ratio, estimated glomerular filtration rate, and low vitamin D concentration. CVD, cardiovascular disease.

2

Continuous [per 0.1-unit increase in phosphorus density (mg/kcal)].

The corrected Tables 3 and 4 are presented below. The figures and the remainder of the analyses remain correct.


Articles from The American Journal of Clinical Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES